Active i Malmö AB

	Start	1991-01-01 existent
	End	1997-10-20 renamed
	Group	Active Biotech (Group)
	Today	Active Biotech AB (Nasdaq OMX Nordic: ACTI)
	Successor	Active Biotech AB (Nasdaq OMX Nordic: ACTI)
	Industry	pharmaceutical

	Region	Malmö
	Country	Sweden
	City	n. a.
		Address record changed: 2011-05-15

Basic data	Employees	n. a.


		Record changed: 2024-02-12

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Active Biotech (Group)

[1] Active Biotech AB. (8/4/22). "Press Release: Active Biotech Announces a Rights Issue of approximately SEK 55 Million [Not for release in US, AU, CA, JP, et al.]"....
[2] Active Biotech AB. (12/1/17). "Press Release: Active Biotech Announce Results in ARPEGGIO Phase II Trial with Laquinimod in Primary Progressive MS". Lund....
[3] Active Biotech AB. (6/19/17). "Press Release: Helén Tuvesson New CEO of Active Biotech AB from July 1, 2017". Lund....
[4] Active Biotech AB. (5/5/17). "Press Release: Teva and Active Biotech Announce CONCERTO Trial of Laquinimod in RRMS Did Not Meet Primary Endpoint". Jerusalem & Lund....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)